Science Explorer Interactive view Map
Company · Basiglio · Italy

AstraZeneca (Italy)

astrazeneca.itROR OpenAlex
Research works
92
▲ 204% vs 2013–17
Citations
1.4k
15.6 per fractional work
Top-10% rate
18.8%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: AstraZeneca (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.02× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 2.44× its world share, 1 worksImmunology and Micro…Neuroscience: 0.19× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.23× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.44× its world share, 0 worksChemistryComputer Science: 0.23× its world share, 1 worksComputer ScienceEngineering: 0.14× its world share, 1 worksEngineeringEnvironmental Science: 0.21× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.12× its world share, 0 worksMaterials ScienceMathematics: 0.70× its world share, 0 worksMathematicsHealth Professions: 1.44× its world share, 2 worksHealth ProfessionsMedicine: 3.37× its world share, 27 worksMedicineNursing: 0.83× its world share, 0 worksNursingBusiness, Management and Accounting: 0.21× its world share, 0 worksBusiness, Management…Decision Sciences: 0.23× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.68× its world share, 2 worksEconomics, Econometr…Psychology: 0.38× its world share, 0 worksPsychologySocial Sciences: 0.14× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.4×. Every wedge is a field page.

Which keywords describe research at AstraZeneca (Italy)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Treatment, Inflammation, Diagnosis, Epidemiology, Global Burden, Cardiovascular Disease, Autoantibodies and Heart Failure.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Epidemiology6▲ 3.5×19 topics
  2. Inflammation5▲ 6.0×31 topics
  3. Treatment5▲ 9.7×12 topics
  4. Diagnosis4▲ 11×8 topics
  5. Global Burden4▲ 17×3 topics
  6. Cardiovascular Disease4▲ 7.6×15 topics
  7. Autoantibodies3▲ 35×4 topics
  8. Heart Failure3▲ 17×11 topics
  9. Management3▲ 9.1×4 topics
  10. Quality of Life3▲ 4.9×8 topics
  11. Asthma3▲ 69×2 topics
  12. Genetics3▲ 9.3×3 topics
  13. Immunology3▲ 60×2 topics
  14. Allergic Diseases2▲ 101×1 topic
  15. Eosinophils2▲ 101×1 topic
  16. Toll-like Receptors2▲ 53×2 topics
  17. Antiphospholipid Syndrome2▲ 120×1 topic
  18. COPD2▲ 89×1 topic
  19. Systemic Lupus Erythematosus2▲ 107×1 topic
  20. spirometry2▲ 89×1 topic
  21. Chronic Kidney Disease2▲ 22×7 topics
  22. Fibrosis2▲ 23×6 topics
  23. Clinical Guidelines2▲ 12×4 topics
  24. Cost-effectiveness Analysis1▲ 37×1 topic
  25. Health Utility Measures1▲ 37×1 topic
  26. Machine Learning1◆ 0.93×5 topics
  27. Glycemic Control1▲ 19×4 topics
  28. Guidelines1▲ 6.2×4 topics
  29. Nanoparticles1▲ 2.3×5 topics
  30. TGF-ß1▲ 19×4 topics
  31. Cancer1▲ 1.91×10 topics
  32. Cardiovascular Risk1▲ 8.4×6 topics
  33. Hypertension1▲ 9.4×8 topics
  34. Insulin Therapy1▲ 22×3 topics
  35. Obesity1▲ 3.2×5 topics
  36. Public Health1▲ 1.71×7 topics

Which research topics does AstraZeneca (Italy) publish most on?

By volume in 2022–2025: Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Systemic Lupus Erythematosus Research and Health Systems, Economic Evaluations, Quality of Life.

Asthma and respiratory diseases: 2 fractional worksChronic Obstructive Pulmonary Disease (COPD) Research: 2 fractional worksSystemic Lupus Erythematosus Research: 2 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksPharmaceutical Economics and Policy: 1 fractional worksInhalation and Respirato…1Inhalation and Respiratory Drug Delivery: 1 fractional worksDiabetes Treatment and Management: 1 fractional worksChronic Kidney Disease and Diabetes: 1 fractional worksRespiratory and Cough-Related Research: 1 fractional worksDelphi Technique in Research: 1 fractional works
PhysiologyPulmonary and Respiratory MedicineRheumatologyEconomics and Econometrics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Asthma and respiratory diseases Physiology 2 works
  2. 2 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
  3. 3 Systemic Lupus Erythematosus Research Rheumatology 2 works
  4. 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  5. 5 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  6. 6 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
  7. 7 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  8. 8 Chronic Kidney Disease and Diabetes Nephrology 1 works
  9. 9 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 1 works
  10. 10 Delphi Technique in Research Sociology and Political Science 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.0%not open47.0%

World: 28% of research is openly available.

with international co-authors60.9%domestic only39.1%

World: 19% is written across borders.

How has AstraZeneca (Italy)'s research output changed?

Output in 2018–2022 was 204% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.